Loading company…
Switch Therapeutics develops medicines for central nervous system diseases using its CASi RNA platform.
Switch Therapeutics is a preclinical biotechnology company developing medicines for diseases of the central nervous system and other organs. Its CASi platform combines features of single- and double-stranded RNA in one molecule. Founded in 2020 by Dee Datta and Si-ping Han, the company is based in South San Francisco, US. In March 2023, it raised an undisclosed amount of venture funding from Global Brain.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in